Point-of-Care Drug Testing.

Area of Science:

• Analytical Chemistry
• Biotechnology
• Clinical Diagnostics

Background:

• Drug detection is crucial in clinical, legal, and workplace settings.
• Traditional laboratory testing methods can be time-consuming and resource-intensive.
• Point-of-Care Testing (POCT) has emerged as a vital alternative for rapid drug screening.

Purpose of the Study:

• To provide a comprehensive review of Point-of-Care Testing (POCT) for drug detection.
• To explore the advancements, applications, and challenges associated with POCT drug testing.
• To discuss future innovations and the potential impact of POCT on drug detection strategies.

Main Methods:

• Review of existing literature on drug detection technologies, focusing on POCT.
• Analysis of the evolution of immunoassay and biosensor technologies for drug screening.
• Examination of the benefits and drawbacks of POCT in various settings.

Main Results:

• POCT technologies, including immunoassays and biosensors, have significantly advanced drug detection.
• Key benefits include rapid results, enhanced accessibility, and cost-effectiveness.
• Challenges remain concerning accuracy, regulatory approval, and standardization.

Conclusions:

• POCT offers a transformative approach to drug detection with significant advantages over traditional methods.
• Addressing challenges in accuracy and standardization is crucial for wider adoption.
• Future integration with digital health and advanced devices will further enhance POCT capabilities.